Repurposing of terconazole as an anti Trypanosoma cruzi agent

Trypanosoma cruzi is the causative agent of Chagas disease, a parasitic infection endemic in Latin America. Currently there are no effective treatments for the chronic phase of the disease, when most patients are diagnosed, therefore the development of new drugs is a priority area. Several triazoles...

Descripción completa

Detalles Bibliográficos
Autores principales: Reigada, Chantal, Sayé, Melisa, Valera-Vera, Edward, Miranda, Mariana R., Pereira, Claudio A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562323/
https://www.ncbi.nlm.nih.gov/pubmed/31211266
http://dx.doi.org/10.1016/j.heliyon.2019.e01947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562323/
https://www.ncbi.nlm.nih.gov/pubmed/31211266
http://dx.doi.org/10.1016/j.heliyon.2019.e01947

Ejemplares similares